Doxepin HCL 3 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FVWHA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,102
Award facts
- Contract value 100% obligated
- $1,102.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Doxepin HCL 3 mg tablets (30-count units) with a ceiling value of $1,102.17. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and has an ultimate completion date of September 12, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA supply chain. The company maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, including neurological, pain management, diabetes, and antibiotic treatments. The IDC vehicle under which this delivery order falls supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, positioning AmerisourceBergen as a key provider within the DLA's Pharmaceutical Prime Vendor program supporting military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FVWHA?
SPE2DB25FVWHA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FVWHA worth?
The government has obligated $1,102 on SPE2DB25FVWHA.
Is contract SPE2DB25FVWHA an order under another contract?
Yes. SPE2DB25FVWHA is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVWHA competed?
The extent of competition for SPE2DB25FVWHA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award